The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mackay Martin since 2014.
This trader's CIK number is 1414815.
At the time of last reporting, Mackay Martin was the Chief Executive Officer of Rallybio Corp. (stock ticker symbol RLYB).
Also see all insider trading activities at Rallybio Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | RLYB | 10,000 | $103,472 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ALXN | 0 | $0 | 4,800 | $616,197 | 0 | $0 |
| 2016 | ALXN | 0 | $0 | 9,168 | $1,286,066 | 0 | $0 |
| 2015 | ALXN | 0 | $0 | 51,823 | $9,934,397 | 43,500 | $6,126,105 |
| 2014 | ALXN | 0 | $0 | 37,949 | $6,533,952 | 34,375 | $3,604,562 |
2. Alexion Pharmaceuticals, Inc. (ALXN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-01-10 | RLYB | Buy | 5,504 | 10.10 | 55,590 |
| 2022-01-11 | RLYB | Buy | 4,496 | 10.65 | 47,882 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-02-27 | ALXN | Sale | 860 | 131.20 | 112,831 |
| 2017-02-28 | ALXN | Sale | 625 | 131.70 | 82,312 |
| 2017-03-01 | ALXN | Sale | 370 | 132.50 | 49,025 |
| 2017-02-09 | ALXN | Sale | 217 | 126.84 | 27,524 |
| 2017-02-06 | ALXN | Sale | 2,728 | 126.28 | 344,505 |
| 2016-05-16 | ALXN | Sale | 4,097 | 139.81 | 572,801 |
| 2016-02-29 | ALXN | Sale | 1,000 | 138.91 | 138,910 |
| 2016-02-08 | ALXN | Sale | 1,966 | 139.17 | 273,608 |
| 2016-02-05 | ALXN | Sale | 2,105 | 142.87 | 300,747 |
| 2015-08-03 | ALXN | Option Ex | 43,500 | 140.83 | 6,126,105 |
| 2015-08-03 | ALXN | Sale | 43,500 | 196.30 | 8,539,180 |
| 2015-05-14 | ALXN | Sale | 4,056 | 160.33 | 650,298 |
| 2015-03-02 | ALXN | Sale | 370 | 180.34 | 66,725 |
| 2015-02-10 | ALXN | Sale | 3,897 | 174.03 | 678,194 |
| 2014-11-03 | ALXN | Sale | 9,375 | 191.52 | 1,795,500 |
| 2014-11-03 | ALXN | Option Ex | 9,375 | 104.86 | 983,062 |
| 2014-06-12 | ALXN | Sale | 25,000 | 166.54 | 4,163,575 |
| 2014-06-12 | ALXN | Option Ex | 25,000 | 104.86 | 2,621,500 |
| 2014-05-14 | ALXN | Sale | 3,574 | 160.85 | 574,877 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mackay Martin (Chief Executive Officer of Rallybio Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.